This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his Applied Science...
A company of Manulife Investment Management, John Hancock Investment Management serves investors through a unique multimanager approach, complementing our extensive in-house capabilities with an...
ImmunoGen (NASDAQ:IMGN) is a large biopharmaceutical company (market cap of $4.8 billion) that uses antibody-drug conjugate (‘ADC’) technology to develop novel therapeutics against cancer....
Repligen (NASDAQ:RGEN) offers a comprehensive suite of products, including filtration, chromatography, process analytics, and proteins, catering to both upstream and downstream processes in the...
Living with memory loss and other cognitive limitations is hard. But when you can’t remember or can’t process information well enough to make important...
Investment thesis Synaptics (NASDAQ:SYNA) is experiencing severe headwinds due to the challenging environment with weak end markets’ spending. On the other hand, secular trends...